California State Teachers Retirement System (CalSTRS)’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-331
| Closed | -$1.42K | – | 3067 |
|
|
2025
Q4 | $1.42K | Buy |
331
+118
| +55% | +$1.06K | ﹤0.01% | 3033 |
|
|
2025
Q3 | $8.3K | Hold |
213
| – | – | ﹤0.01% | 2894 |
|
|
2025
Q2 | $4.97K | Buy |
+213
| New | +$5.04K | ﹤0.01% | 2904 |
|
|
2024
Q2 | – | Sell |
-148
| Closed | -$4.83K | – | 3197 |
|
|
2024
Q1 | $4.83K | Sell |
148
-66
| -31% | -$1.71K | ﹤0.01% | 3003 |
|
|
2023
Q4 | $5.72K | Sell |
214
-73
| -25% | -$3.02K | ﹤0.01% | 3044 |
|
|
2023
Q3 | $17.3K | Sell |
287
-145
| -34% | -$13.6K | ﹤0.01% | 3008 |
|
|
2023
Q2 | $44K | Sell |
432
-1,145
| -73% | -$158K | ﹤0.01% | 2964 |
|
|
2023
Q1 | $279K | Sell |
1,577
-21
| -1% | -$7.03K | ﹤0.01% | 2511 |
|
|
2022
Q4 | $618K | Buy |
1,598
+18
| +1% | +$6.84K | ﹤0.01% | 2237 |
|
|
2022
Q3 | $532K | Sell |
1,580
-14
| -0.9% | -$5.07K | ﹤0.01% | 2306 |
|
|
2022
Q2 | $524K | Buy |
1,594
+26
| +2% | +$9.12K | ﹤0.01% | 2369 |
|
|
2022
Q1 | $686K | Sell |
1,568
-39
| -2% | -$16K | ﹤0.01% | 2242 |
|
|
2021
Q4 | $704K | Buy |
1,607
+30
| +2% | +$15.1K | ﹤0.01% | 2365 |
|
|
2021
Q3 | $877K | Sell |
1,577
-125
| -7% | -$62.7K | ﹤0.01% | 2219 |
|
|
2021
Q2 | $874K | Sell |
1,702
-25
| -1% | -$15.8K | ﹤0.01% | 2296 |
|
|
2021
Q1 | $1.35M | Hold |
1,727
| – | – | ﹤0.01% | 1955 |
|
|
2020
Q4 | $941K | Hold |
1,727
| – | – | ﹤0.01% | 2077 |
|
|
2020
Q3 | $791K | Buy |
1,727
+27
| +2% | +$15.7K | ﹤0.01% | 2003 |
|
|
2020
Q2 | $1.05M | Buy |
1,700
+29
| +2% | +$16K | ﹤0.01% | 1834 |
|
|
2020
Q1 | $794K | Sell |
1,671
-18
| -1% | -$9.78K | ﹤0.01% | 1807 |
|
|
2019
Q4 | $980K | Sell |
1,689
-35
| -2% | -$24.6K | ﹤0.01% | 1981 |
|
|
2019
Q3 | $1.13M | Buy |
1,724
+266
| +18% | +$221K | ﹤0.01% | 1855 |
|
|
2019
Q2 | $1.13M | Buy |
1,458
+73
| +5% | +$51.3K | ﹤0.01% | 1894 |
|
|
2019
Q1 | $979K | Sell |
1,385
-32
| -2% | -$19.2K | ﹤0.01% | 1952 |
|
|
2018
Q4 | $663K | Buy |
1,417
+33
| +2% | +$21.3K | ﹤0.01% | 2125 |
|
|
2018
Q3 | $1.19M | Buy |
1,384
+231
| +20% | +$167K | ﹤0.01% | 1959 |
|
|
2018
Q2 | $795K | Buy |
1,153
+29
| +3% | +$14.7K | ﹤0.01% | 2195 |
|
|
2018
Q1 | $501K | Sell |
1,124
-46
| -4% | -$22.3K | ﹤0.01% | 2360 |
|
|
2017
Q4 | $516K | Sell |
1,170
-33
| -3% | -$15K | ﹤0.01% | 2389 |
|
|
2017
Q3 | $593K | Sell |
1,203
-112
| -9% | -$56.1K | ﹤0.01% | 2326 |
|
|
2017
Q2 | $729K | Buy |
1,315
+166
| +14% | +$105K | ﹤0.01% | 2260 |
|
|
2017
Q1 | $761K | Sell |
1,149
-53
| -4% | -$28.3K | ﹤0.01% | 2242 |
|
|
2016
Q4 | $402K | Sell |
1,202
-33
| -3% | -$10.6K | ﹤0.01% | 2632 |
|
|
2016
Q3 | $371K | Buy |
1,235
+11
| +0.9% | +$2.38K | ﹤0.01% | 2645 |
|
|
2016
Q2 | $212K | Buy |
1,224
+37
| +3% | +$8.06K | ﹤0.01% | 2891 |
|
|
2016
Q1 | $266K | Buy |
1,187
+164
| +16% | +$49K | ﹤0.01% | 2717 |
|
|
2015
Q4 | $621K | Buy |
1,023
+18
| +2% | +$9.88K | ﹤0.01% | 2284 |
|
|
2015
Q3 | $517K | Buy |
1,005
+158
| +19% | +$106K | ﹤0.01% | 2400 |
|
|
2015
Q2 | $370K | Buy |
847
+572
| +208% | +$221K | ﹤0.01% | 2752 |
|
|
2015
Q1 | $99K | Hold |
275
| – | – | ﹤0.01% | 2983 |
|
|
2014
Q4 | $99K | Buy |
275
+1
| +0.4% | +$322 | ﹤0.01% | 3013 |
|
|
2014
Q3 | $83K | Buy |
274
+2
| +0.7% | +$821 | ﹤0.01% | 3009 |
|
|
2014
Q2 | $167K | Hold |
272
| – | – | ﹤0.01% | 2964 |
|
|
2014
Q1 | $182K | Buy |
+272
| New | +$161K | ﹤0.01% | 2917 |
|
Other funds holding TVRD
SPC
VCM
AFG
SAM
DWAM
California State Teachers Retirement System (CalSTRS)'s TVRD Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) sold out of Tvardi Therapeutics (TVRD) in Q1 2026, closing a stake of 331 shares — an estimated $1.42K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in TVRD in Q1 2014 and held it in 44 quarters. The position peaked at $1.35M in Q1 2021. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) reported no remaining Tvardi Therapeutics position as of Q1 2026 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 331 Tvardi Therapeutics shares in Q1 2026, an estimated $1.42K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Tvardi Therapeutics in Q1 2014 and held it in 44 quarters.
- California State Teachers Retirement System (CalSTRS)'s Tvardi Therapeutics position peaked at $1.35M in Q1 2021.
- 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.